Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Feb;27(2):205-13.
doi: 10.1111/j.1365-2125.1989.tb05352.x.

The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease

Affiliations

The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease

N R Scott et al. Br J Clin Pharmacol. 1989 Feb.

Abstract

1. Serum and salivary concentrations of caffeine (1,3,7-trimethylxanthine) and its dimethylxanthine metabolites were measured in 10 healthy control subjects and in 19 patients with cirrhosis, for up to 96 h following a 400 mg oral caffeine load. 2. Serum and salivary caffeine concentrations correlated significantly (r = 0.954; P less than 0.001) and no significant differences were observed in the pharmacokinetic data derived from the respective concentration-time curves. 3. In the control subjects, basal salivary caffeine concentrations did not exceed 0.4 mg l-1. The median (range) basal salivary caffeine concentrations in patients with compensated cirrhosis (n = 10), 0.2 (0-0.7) mg l-1 and decompensated cirrhosis (n = 9), 0.7 (0-5.8) mg l-1, were not significantly different from control values, although three patients with decompensated cirrhosis had basal salivary caffeine values above 2.0 mg l-1. 4. In the patients with compensated cirrhosis, the median peak salivary caffeine concentration, 10.9 (8.2-16.5) mg l-1 was significantly greater than in controls, 7.1 (4.7-11.8) mg l-1 (P less than 0.01) and the median apparent volume of distribution was significantly reduced, 0.38 (0.19-0.49) vs 0.41 (0.23-0.63) l kg-1 (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Surg. 1973 Aug;60(8):646-9 - PubMed
    1. Clin Pharmacol Ther. 1976 Oct;20(4):484-92 - PubMed
    1. Gastroenterology. 1977 Apr;72(4 Pt 1):573-83 - PubMed
    1. Clin Pharmacol Ther. 1978 Jul;24(1):40-5 - PubMed
    1. Dig Dis Sci. 1980 Mar;25(3):193-7 - PubMed